Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $12.8 million.

  • Dare Bioscience's Shares Outstanding (Weighted Average) rose 4734.12% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 4734.12%. This contributed to the annual value of $8.5 million for FY2024, which is 1679.86% up from last year.
  • Latest data reveals that Dare Bioscience reported Shares Outstanding (Weighted Average) of $12.8 million as of Q3 2025, which was up 4734.12% from $8.9 million recorded in Q2 2025.
  • Dare Bioscience's Shares Outstanding (Weighted Average)'s 5-year high stood at $85.6 million during Q3 2022, with a 5-year trough of $7.2 million in Q2 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $12.8 million (2025), whereas its average is $38.8 million.
  • In the last 5 years, Dare Bioscience's Shares Outstanding (Weighted Average) soared by 12405.71% in 2021 and then crashed by 9144.1% in 2023.
  • Over the past 5 years, Dare Bioscience's Shares Outstanding (Weighted Average) (Quarter) stood at $61.2 million in 2021, then skyrocketed by 38.29% to $84.6 million in 2022, then tumbled by 91.4% to $7.3 million in 2023, then increased by 16.8% to $8.5 million in 2024, then skyrocketed by 50.11% to $12.8 million in 2025.
  • Its last three reported values are $12.8 million in Q3 2025, $8.9 million for Q2 2025, and $8.8 million during Q1 2025.